Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (T2DM)
This study is currently recruiting participants.
Verified March 2013 by Handok Pharmaceuticals Co., Ltd.
Sponsor:
Handok Pharmaceuticals Co., Ltd.
Information provided by (Responsible Party):
Handok Pharmaceuticals Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01805830
First received: December 26, 2012
Last updated: March 5, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |